Insider Transactions in Q1 2025 at Bio Xcel Therapeutics, Inc. (BTAI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2025
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
217
+5.02%
|
-
|
|
Mar 15
2025
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34
+1.78%
|
-
|
|
Mar 15
2025
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34
+2.09%
|
-
|
|
Mar 15
2025
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
34
+2.42%
|
-
|
|
Mar 14
2025
|
Vimal Mehta CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
162
+4.0%
|
-
|
|
Mar 14
2025
|
Frank Yocca Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31
+1.66%
|
-
|
|
Mar 14
2025
|
Javier Rodriguez Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31
+1.95%
|
-
|
|
Mar 14
2025
|
Richard I Steinhart Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31
+2.26%
|
-
|
|
Feb 28
2025
|
David J. Mack Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,693
+20.0%
|
-
|
|
Jan 31
2025
|
David J. Mack Director |
BUY
Exercise of conversion of derivative security
|
Direct |
27,089
+25.0%
|
-
|